Concepedia

Antonios Douros

AD

41

Publications

1.7K

Citations

23

H-Index

2013

Active since

Affiliations

Charité - Universitätsmedizin Berlin(Current)

Jewish General Hospital

McGill University

Humboldt-Universität zu Berlin

Freie Universität Berlin

Antonios Douros is an author at Charité - Universitätsmedizin Berlin specializing in medicine, pharmacology, and cardiovascular disease.

ORCID

Top concepts

Publications per year

2013–2024

41

Publications

41

Sodium–Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis

Antonios Douros, Lisa M. Lix, Michael Fralick et al. · Annals of Internal Medicine · 2020 · 168 citations

Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study

Antonios Douros, Sophie Dell’Aniello, Oriana Hoi Yun Yu et al. · BMJ · 2018 · 126 citations · Full text

, , +22

Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study

Devin Abrahami, Antonios Douros, Hui Yin et al. · BMJ · 2018 · 118 citations · Full text

Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study

Kristian B. Filion, Lisa M. Lix, Oriana HY Yu et al. · BMJ · 2020 · 117 citations · Full text

Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events

Antonios Douros, Hui Yin, Oriana Hoi Yun Yu et al. · Diabetes Care · 2017 · 91 citations

Rows per page

1–5 of 41